Castle to share data on clinical value skin cancer test at Hawaii conference

Castle Biosciences announced that new data supporting the clinical value of the Company’s skin cancer test portfolio is being shared in poster presentations at the 2023 Winter Clinical Dermatology Conference – Hawaii , being held Jan. 13-18 in Kohala Coast, Hawaii. "At Castle, we are committed to challenging the status quo to improve disease management through deep scientific expertise, unique value insight and strong data development," said Derek Maetzold, president and chief executive officer of Castle Biosciences. "The data that we are presenting at the 2023 Winter Clinical Dermatology Conference – Hawaii demonstrates the ability of our tests to help guide personalized and risk-aligned patient management decisions with a goal of enabling better patient outcomes." The posters below will be displayed for viewing in the Grande Ballroom Salon III for the duration of the conference.